Both companies demonstrate strong ESG management, particularly for product governance
According to the IFEBP survey, the top 10 factors when considering covering GLP-1 drugs for obesity are: Obesity as a risk factor for chronic diseases and associated costs Drug shortages Impact/effectiveness of cost-control mechanisms Existing coverage through government programs Long-term costs Patient and prescriber demand Broker/consultant/ PBM recommendations Lack of long-term use clinical studies of GLP-1 drugs Side effects Similar drugs in research and development The cost of these drugs can range from a minimum of $200 to $300 a month, and this cost would stretch over a long period of time, as GLP-1 drugs for weight loss require prolonged use, Bajaj said
Memory is unreliable
This excess estradiol then suppresses gonadotropin-releasing hormone (GnRH) in the hypothalamus, which reduces LH and FSH output from the pituitary, which further reduces testosterone production from the testes
A painless, non-invasive body composition analysis provides a complete baseline health picture within minutes, revealing precise data on fat distribution, muscle mass, metabolic rate, and hydration levels